TransCode Therapeutics Inc [NASDAQ: RNAZ] traded at a high on Thursday, posting a 57.59 gain after which it closed the day’ session at $5.50.
The results of the trading session contributed to over 10810392 shares changing hands. Over the past one week, the price volatility of TransCode Therapeutics Inc stands at 60.28% while the volatility over the past one month is 24.29%.
The market cap for RNAZ stock reached $3.83 million, with 0.70 million shares outstanding and 0.70 million shares in the current float. Compared to the average trading volume of 64.28K shares, RNAZ reached a trading volume of 10810392 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about TransCode Therapeutics Inc [RNAZ]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for RNAZ shares is $20.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on RNAZ stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for TransCode Therapeutics Inc is set at 1.21 The Price to Book ratio for the last quarter was 1.74, with the Price to Cash per share for the same quarter was set at 2.70.
How has RNAZ stock performed recently?
TransCode Therapeutics Inc [RNAZ] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 72.41. With this latest performance, RNAZ shares gained by 42.86% in over the last four-week period, additionally sinking by -45.09% over the last 6 months – not to mention a drop of -80.16% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for RNAZ stock in for the last two-week period is set at 56.04, with the RSI for the last a single of trading hit 73.16, and the three-weeks RSI is set at 47.15 for TransCode Therapeutics Inc [RNAZ]. The present Moving Average for the last 50 days of trading for this stock 7.20, while it was recorded at 3.84 for the last single week of trading, and 18.55 for the last 200 days.
TransCode Therapeutics Inc [RNAZ]: Deeper insight into the fundamentals
TransCode Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.58 and a Current Ratio set at 1.58.
Insider trade positions for TransCode Therapeutics Inc [RNAZ]
There are presently around $1.99%, or 1.99%% of RNAZ stock, in the hands of institutional investors.
